trial · primary record
HRS-7172 + AG + SHR-1316
Pancreatic Cancer
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 140 |
| Primary completion | 2029-12-31 |
| Primary endpoint | RDE in advanced pancreatic cancer with RAS mutation or amplification |
| Registry ID | NCT07806058 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:14.013Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07806058
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.